Intelligent Medicine Acquisition (IQMD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IQMD Annual Balance Sheets →
Balance sheet data covering Intelligent Medicine Acquisition–Dec 31 2021 offers a view into how Dec 31 2022's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.05
Cash & Short-term Investments0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.14
Total Current Assets0.19
Other Assets, Noncurrent213.85
Total Assets214.03
Liabilities
Accounts Payable, Current AC0.47
Other Liabilities, Current0.58
Taxes Payable0.03
Total Current Liabilities1.08
Total Long-term Debt0.00
Other liabilities, Noncurrent10.56
DeferredOfferingCostsNoncurrent10.35
Accrued Offering Costs0.02
Total Liabilities11.64
Stockholders' Equity
Common Stock Value0.00
Retained Earnings / Accumulated Deficit-10.86
Other Equity-213.26
Common Stockholder's Equity-224.11
Non-controlling interests & other213.26
Total Stockholder's Equity-10.86
Liabilities & Stockholder's Equity214.03
4 historic quarters locked

Sign in to unlock the full Intelligent Medicine Acquisition balance sheet history.

About Intelligent Medicine Acquisition Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-23-046201

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License